(University of Louisville) The first three patients to undergo an investigational surgical procedure for peripheral vascular disease that involves the patient's own stem cells continue to do well, reports the University of Louisville surgeon who is the principal investigator.
The "TGI-PVG IDE" clinical trial initiated at UofL involves using a patient's own stem cells to line man-made bypass grafts to better the chances at saving the limbs of patients with peripheral artery disease.
peripheral vascular diseaseUniversity of Louisville surgeons perform first prosthetic bypas...EurekAlert! - Medicine and Health Thu, 06/16/2011 - 22:00
Daily Checkup: Treatment of peripheral vascular disease is simpl...NYDailyNews.com - Health - NY Daily News Tue, 04/20/2010 - 21:05
Though it affects about 10 million Americans, peripheral vascular disease (PVD) is hardly a household term. "Peripheral vascular disease typically refers to the impairment of blood flow to the legs," says Dr. The NIH Trial to Assess Chelation Therapy (TACT): an unethical s...Health Care Renewal Fri, 05/16/2008 - 06:00
Two occasional HCR bloggers are co-authors of an article published this week: Why the NIH Trial to Assess Chelation Therapy (TACT) Should Be Abandoned Tags:
|
